Value of genetic and genomic technologies
Work detail
"Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice"--home page.
Overview
Shared work-level identity and catalog context.
Contributors
People credited with this work in the active catalog.
- Open Author
Theresa M. Wizemann
- Open Author
Institute of Medicine
- Open Author
Board on Health Sciences Policy
- Open Author
Adam C. Berger
- Open Author
Theresa Wizemann
- Open Author
Roundtable on Translating Genomic-Based Research for Health
Editions
Publication-specific versions linked to this work only.
- Image source: Open LibraryVO
Value of genetic and genomic technologies
- VOValue of Genetic and Genomic Te...Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Theresa Wizemann
Value of Genetic and Genomic Technologies
- VOValue of Genetic and Genomic Te...Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Theresa Wizemann, Board on Health Sciences Policy, Institute of Medicine
Value of Genetic and Genomic Technologies
- VOValue of Genetic and Genomic Te...Institute of Medicine, Board on Health Sciences Policy, Roundtable on Translating Genomic-Based Research for Health, Adam C. Berger, Theresa Wizemann
Value of Genetic and Genomic Technologies
- VOValue of Genetic and Genomic Te...Theresa Wizemann, Adam C. Berger
Value of Genetic and Genomic Technologies